Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC
- Status
- TERMINATED
- Phase
- PHASE2
Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comparison Between Corticosteroid and Topical Steroids in the DRESS
- Status
- UNKNOWN
- Phase
- NA
Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease
- Status
- COMPLETED
- Phase
- PHASE4
The Effect of Prednisone on Physical Exercise in COPD Patients
- Status
- COMPLETED
- Phase
- PHASE4
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Abiraterone Acetate for Castrate Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- NA
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
- Status
- TERMINATED
- Phase
- PHASE2
Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide
- Status
- COMPLETED
- Phase
- PHASE2
Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)
- Status
- TERMINATED
- Phase
- PHASE2
S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
- Status
- COMPLETED
- Phase
- PHASE3
Belatacept Therapy for the Failing Renal Allograft
- Status
- COMPLETED
- Phase
- PHASE3
Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
- Status
- COMPLETED
- Phase
- PHASE2